Prospective Study of Hormone Levels After Bariatric Surgery
Status: | Recruiting |
---|---|
Conditions: | Obesity Weight Loss |
Therapuetic Areas: | Endocrinology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/13/2017 |
Start Date: | March 2015 |
End Date: | October 2018 |
Contact: | Gerardo Febres, MD |
Email: | gjf41@columbia.edu |
Phone: | 212-342-0281 |
Prospective Study of Hormone Levels and Appetite After Bariatric Surgery
This project will study the effects of surgery for obesity on bone metabolism and hormones
that regulate appetite.
that regulate appetite.
Subjects will be recruited from the outpatient obesity and surgical clinics at
Columbia-Presbyterian Medical Center after they have chosen to undergo a surgical procedure.
The groups will not be randomized. Rather, they will decide on their choice of surgery along
with their physicians. The patients will be evaluated pre-operatively and followed
post-operatively for 5 years.
Initial evaluation will include a complete history and physical examination, measurement of
calcium, parathyroid hormone (PTH) and vitamin D, and assessment of skeletal health using
markers of bone turnover and bone mineral density.
Columbia-Presbyterian Medical Center after they have chosen to undergo a surgical procedure.
The groups will not be randomized. Rather, they will decide on their choice of surgery along
with their physicians. The patients will be evaluated pre-operatively and followed
post-operatively for 5 years.
Initial evaluation will include a complete history and physical examination, measurement of
calcium, parathyroid hormone (PTH) and vitamin D, and assessment of skeletal health using
markers of bone turnover and bone mineral density.
Inclusion criteria:
1. Adult male or female > 18 years of age
2. Scheduled to undergo bariatric surgery
Exclusion criteria:
1. Vitamin D deficiency
2. Primary hyperparathyroidism
3. Treatment with lithium or thiazide diuretics which may alter PTH levels
4. Osteomalacia
5. Untreated hyperthyroidism, liver disease, Cushing's syndrome, rheumatoid arthritis,
myeloma or Paget's disease
6. Impaired renal function (serum creatinine >2.0mg/dl) or history of renal
osteodystrophy
7. Use of any anti-obesity medications for over 2 weeks 90 days prior to study
8. Participation in any research study 90 days prior to study
9. Any malabsorption syndromes such as celiac sprue
10. Previous bariatric surgery
We found this trial at
1
site
630 W 168th St
New York, New York
New York, New York
212-305-2862
Phone: 212-342-0281
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
Click here to add this to my saved trials